| CUSTOMER |
CUSTOMER |
90%
|
For the year ended December 31, 2025 and 2024, the Company had one customer that accounted for approximately 97.5 % and 96.0 % of pharmaceutical development revenues, respectively. |
| RPRX |
Royalty Pharma plc |
72%
|
Reciprocal relationship from RPRX graph: Reciprocal relationship from SWKH graph: key personnel were to join or form a competitor, our business could similarly suffer a material adverse effect. In ad… |
| RPRX |
Royalty Pharma plc |
72%
|
key personnel were to join or form a competitor, our business could similarly suffer a material adverse effect. In addition, we have very few employees, so the loss of any employee could be disruptiv… |
| RWAY |
Runway Growth Finance Corp. |
72%
|
Reciprocal relationship from RWAY graph: Reciprocal relationship from SWKH graph: Reciprocal relationship from RWAY graph: Reciprocal relationship from SWKH graph: Reciprocal relationship from RWAY g… |
| RWAY |
Runway Growth Finance Corp. |
72%
|
ents, considering a “management approach” concept as the basis for identifying reportable segments. The management approach is based on the way that management organizes the segments within the Compa… |
| BEST-ABT-INC |
BEST-ABT-INC |
62%
|
ns Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, interest and accounts receivable, finance re… |
| DELAWARE-GENERAL-CORPORATION |
DELAWARE-GENERAL-CORPORATION |
62%
|
key personnel were to join or form a competitor, our business could similarly suffer a material adverse effect. In addition, we have very few employees, so the loss of any employee could be disruptiv… |
| ENTERIS-BIOPHARMA-INC |
ENTERIS-BIOPHARMA-INC |
62%
|
form. The Company was originally incorporated in California in July 1996 and reincorporated in Delaware in September 1999. The Company is headquartered in Dallas, Texas, and had 9 full-time employees… |
| FLOWONIX-MEDICAL-INC |
FLOWONIX-MEDICAL-INC |
62%
|
ns Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, interest and accounts receivable, finance re… |
| IDEAL-IMPLANT-INC |
IDEAL-IMPLANT-INC |
62%
|
ns Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, interest and accounts receivable, finance re… |
| RUNWAY-GROWTH-CAPITAL-LLC |
RUNWAY-GROWTH-CAPITAL-LLC |
62%
|
hanges in market interest rates. In periods of rising interest rates when we have debt outstanding, our cost of funds would increase, which could reduce our income, especially to the extent we contin… |
| RUNWAY-GROWTH-FINANCE-CORPORATION |
RUNWAY-GROWTH-FINANCE-CORPORATION |
62%
|
ents, considering a “management approach” concept as the basis for identifying reportable segments. The management approach is based on the way that management organizes the segments within the Compa… |
| RWAY-PORTFOLIO-CORP |
RWAY-PORTFOLIO-CORP |
62%
|
hanges in market interest rates. In periods of rising interest rates when we have debt outstanding, our cost of funds would increase, which could reduce our income, especially to the extent we contin… |
| RWAY-PORTFOLIO-HOLDING-CORP |
RWAY-PORTFOLIO-HOLDING-CORP |
62%
|
hanges in market interest rates. In periods of rising interest rates when we have debt outstanding, our cost of funds would increase, which could reduce our income, especially to the extent we contin… |
| SWK-FUNDING-LLC |
SWK-FUNDING-LLC |
62%
|
key personnel were to join or form a competitor, our business could similarly suffer a material adverse effect. In addition, we have very few employees, so the loss of any employee could be disruptiv… |
| SWK-HOLDINGS-CORPORATION |
SWK-HOLDINGS-CORPORATION |
62%
|
ents, considering a “management approach” concept as the basis for identifying reportable segments. The management approach is based on the way that management organizes the segments within the Compa… |
